![Catherine Mathis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Catherine Mathis
No más puestos en curso
Perfil
Catherine Mathis served as Director of Regulatory Affairs at Transgene SA from 1994 to 2014.
She then worked as Senior Director of Regulatory Affairs at Voisin Consulting, Inc. in 2014-2015.
In 2016, she became Vice President of Regulatory Affairs at Sangamo Therapeutics France SAS, and later that year, she became the Chief Operating Officer at ElsaLys Biotech SAS, where she worked until 2019.
Dr. Mathis holds a graduate degree from Université Paris 1 Panthéon-Sorbonne and a doctorate from Université de Paris 5 René Descartes.
Antiguos cargos conocidos de Catherine Mathis.
Empresas | Cargo | Fin |
---|---|---|
ELSALYS BIOTECH | Director de Operaciones | 01/02/2019 |
TXCELL | Consejero General | 01/09/2016 |
Voisin Consulting, Inc.
![]() Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Consejero General | 01/12/2015 |
TRANSGENE | Consejero General | 01/10/2014 |
Formación de Catherine Mathis.
Université Paris 1 Panthéon-Sorbonne | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
TRANSGENE | Health Technology |
Empresas privadas | 4 |
---|---|
Université de Paris 5 René Descartes | Consumer Services |
Sangamo Therapeutics France SAS
![]() Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
ElsaLys Biotech SAS
![]() ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
Voisin Consulting, Inc.
![]() Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Catherine Mathis